It's our 18th anniversary!

Immunization from Poverty

Investment from 5,400 USD

Investment period until: 15/09/2017

Expected
yearly returns
51%

Having come into operation in 1849 as a small company manufacturing light chemicals, Pfizer rose to become a global leader in the pharmaceutical market, conducting its operations in over 150 countries of the world and having a diversified portfolio of innovative medicines for treating and preventing many different medical conditions. The company’s geographical revenue diversification (share): US – 44.4%, emerging markets – 22.8%, Europe – 19.9%, other countries – 12.9%. Largest shareholders in the company include: Blackrock (6.89%), Goldman Sachs (2.11%), Bank of America (1.71%) and J.P. Morgan Chase & Co (1.46%).

Growth Factors:

  • The recent purchase of Hospira, one of the leading manufacturers of injectable drugs, generic drugs and biosimilars, will provide for an extension of the company’s medicine product range: the technology received will allow Pfizer to soon start producing alternative medicines whose patent protection has or is running out.
  • The prolonged growth of the company’s business: revenue in the previous quarter was 19.7% (YoY).
  • High marginality: net profit to revenue for the previous year was 23.9%. Return on equity is 10.23%. Return on assets is 4.15%.
  • Low debt level: aggregate debt to assets is just 24.16%, aggregate debt to EBITDA is 2.19 and net debt to EBITDA is 1.11.
  • The company is trading with a discount (undervalued) in relation to analogues:
    • Discount for P/E against analogues is 20%.
    • Discount for EV/EBITDA against analogues is 19%.
    • Discount for EV/EBIT against analogues is 22%.
    • Discount for EV/Revenue against analogues is 6%.
    • Discount for P/BV against analogues is 33%.

Investment period ends:
15/09/2017

Expected yield is calculated according to 98% capital protection and the price of the base asset at expiry, equal to 49 USD.

Technical Analysis:

Pfizer’s share price has broken upwards through the 50-, 100- and 200-daily moving averages and has left the Ichimoku indicator cloud upwards. The price movements for shares are continuing to sit in an upward long-term trend. The significant technical levels are: 28.56; 30.81; 33.15; 35.54; 39.58; 45.06; 48.66.

Invest

Three simple steps to invest

  • Register for myAlpari, to receive access to the Alpari's services
  • Select an investment idea or create your own investment product!
  • Make a deposit to your transitory account using the means that suit you best and invest your money!

Didn't find the idea for you?

There are more opportunities to create your own product than you think

Create Your Own Product
Back to top